Ellen A. Cannady

666 total citations
21 papers, 456 citations indexed

About

Ellen A. Cannady is a scholar working on Oncology, Pharmacology and Surgery. According to data from OpenAlex, Ellen A. Cannady has authored 21 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pharmacology and 6 papers in Surgery. Recurrent topics in Ellen A. Cannady's work include Drug Transport and Resistance Mechanisms (10 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Lipoproteins and Cardiovascular Health (5 papers). Ellen A. Cannady is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Lipoproteins and Cardiovascular Health (5 papers). Ellen A. Cannady collaborates with scholars based in United States, Australia and United Kingdom. Ellen A. Cannady's co-authors include Nathan B. Mantlo, Robert J. Schmidt, Youyan Zhang, Sandra L. Cockerham, Thomas P. Beyer, Jeffrey G. Suico, Christopher D. Payne, Patricia B. Hoyer, Guoqing Cao and I.G. Sipes and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Lipid Research and Annals of the Rheumatic Diseases.

In The Last Decade

Ellen A. Cannady

21 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen A. Cannady United States 11 121 103 88 87 74 21 456
Miao Hu China 14 118 1.0× 167 1.6× 25 0.3× 100 1.1× 65 0.9× 24 523
Ellen Scheers Belgium 10 81 0.7× 73 0.7× 103 1.2× 138 1.6× 73 1.0× 13 403
Vinayak Hosagrahara United States 13 138 1.1× 135 1.3× 49 0.6× 307 3.5× 137 1.9× 17 598
Maxine Taylor United Kingdom 12 75 0.6× 83 0.8× 28 0.3× 111 1.3× 133 1.8× 14 436
Lisa J. Christopher United States 15 60 0.5× 339 3.3× 162 1.8× 234 2.7× 181 2.4× 41 897
Sang Seop Lee South Korea 20 64 0.5× 327 3.2× 87 1.0× 237 2.7× 326 4.4× 40 859
Marianne K. DeGorter Canada 11 165 1.4× 148 1.4× 45 0.5× 205 2.4× 78 1.1× 16 644
Benny Amore United States 17 87 0.7× 278 2.7× 21 0.2× 258 3.0× 103 1.4× 33 927

Countries citing papers authored by Ellen A. Cannady

Since Specialization
Citations

This map shows the geographic impact of Ellen A. Cannady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen A. Cannady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen A. Cannady more than expected).

Fields of papers citing papers by Ellen A. Cannady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen A. Cannady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen A. Cannady. The network helps show where Ellen A. Cannady may publish in the future.

Co-authorship network of co-authors of Ellen A. Cannady

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen A. Cannady. A scholar is included among the top collaborators of Ellen A. Cannady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen A. Cannady. Ellen A. Cannady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carfagna, Mark A., et al.. (2017). Carcinogenicity assessment of baricitinib in Tg.rasH2 mice and Sprague-Dawley (Crl:CD) rats. Regulatory Toxicology and Pharmacology. 92. 458–471. 7 indexed citations
2.
Posada, Maria M., Ellen A. Cannady, Christopher D. Payne, et al.. (2017). Prediction of Transporter‐Mediated Drug‐Drug Interactions for Baricitinib. Clinical and Translational Science. 10(6). 509–519. 55 indexed citations
3.
Breslin, William J., et al.. (2017). Fertility and Embryo‐Fetal Development Assessment in Rats and Rabbits with Evacetrapib: A Cholesteryl Ester Transfer Protein Inhibitor. Birth Defects Research. 109(7). 513–527. 1 indexed citations
4.
Breslin, William J., et al.. (2017). Prenatal and Postnatal Assessment in Rabbits with Evacetrapib: A Cholesteryl Ester Transfer Protein Inhibitor. Birth Defects Research. 109(7). 486–496. 1 indexed citations
5.
Small, David S., et al.. (2016). Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib. European Journal of Clinical Pharmacology. 72(5). 563–572. 1 indexed citations
6.
Small, David S., et al.. (2016). Impact of Increased Gastric pH on the Pharmacokinetics of Evacetrapib in Healthy Subjects. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 36(7). 749–756. 4 indexed citations
7.
Small, David S., Wei Zhang, Jane Royalty, et al.. (2015). A Multidose Study to Examine the Effect of Food on Evacetrapib Exposure at Steady State. Journal of Cardiovascular Pharmacology and Therapeutics. 20(5). 483–489. 8 indexed citations
8.
Cannady, Ellen A., Stuart Friedrich, Jessica Rehmel, et al.. (2015). Evacetrapib: in vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors. Pharmacology Research & Perspectives. 3(5). e00179–e00179. 6 indexed citations
9.
Cannady, Ellen A., Aktham Aburub, Chris Ward, et al.. (2015). Absolute bioavailability of evacetrapib in healthy subjects determined by simultaneous administration of oral evacetrapib and intravenous [13C8]‐evacetrapib as a tracer. Journal of Labelled Compounds and Radiopharmaceuticals. 59(6). 238–244. 12 indexed citations
10.
Génin, Michaël, Ana B. Bueno, Peter R. Manninen, et al.. (2015). Discovery of 6-(4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1H-indole-3-carboxylic Acid: A Novel FXR Agonist for the Treatment of Dyslipidemia. Journal of Medicinal Chemistry. 58(24). 9768–9772. 52 indexed citations
11.
Cannady, Ellen A., Jeffrey G. Suico, Stuart Friedrich, et al.. (2015). CYP‐mediated drug–drug interactions with evacetrapib, an investigational CETP inhibitor: in vitro prediction and clinical outcome. British Journal of Clinical Pharmacology. 80(6). 1388–1398. 8 indexed citations
12.
Suico, Jeffrey G., Stuart Friedrich, Ellen A. Cannady, et al.. (2014). Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults. Journal of Pharmacy and Pharmacology. 66(11). 1576–1585. 31 indexed citations
13.
Escribano, Ana, Sandra L. Cockerham, Thomas P. Beyer, et al.. (2012). Design and synthesis of new tetrahydroquinolines derivatives as CETP inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(11). 3671–3675. 9 indexed citations
14.
Escribano, Ana, Saravanan Parthasarathy, Xiaodong Wang, et al.. (2012). Design, synthesis and structure–activity-relationship of 1,5-tetrahydronaphthyridines as CETP inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(9). 3056–3062. 25 indexed citations
15.
Cao, Guoqing, Thomas P. Beyer, Youyan Zhang, et al.. (2011). Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure. Journal of Lipid Research. 52(12). 2169–2176. 93 indexed citations
16.
Cannady, Ellen A., et al.. (2007). Involvement of CYP 2E1 enzyme in ovotoxicity caused by 4-vinylcyclohexene and its metabolites. Toxicology and Applied Pharmacology. 221(2). 215–221. 23 indexed citations
17.
18.
19.
Cannady, Ellen A.. (2002). Expression and Activity of Microsomal Epoxide Hydrolase in Follicles Isolated from Mouse Ovaries. Toxicological Sciences. 68(1). 24–31. 41 indexed citations
20.
Hoyer, Patricia B., et al.. (2001). Mechanisms of Ovotoxicity Induced by Environmental Chemicals: 4-Vinylcyclohexene Diepoxide as a Model Chemical. Advances in experimental medicine and biology. 500. 73–81. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miao Hu Breakdown of academic impact, for papers by Ellen Scheers Breakdown of academic impact, for papers by Vinayak Hosagrahara Breakdown of academic impact, for papers by Maxine Taylor Breakdown of academic impact, for papers by Lisa J. Christopher Breakdown of academic impact, for papers by Sang Seop Lee Breakdown of academic impact, for papers by Marianne K. DeGorter Breakdown of academic impact, for papers by Benny Amore
Rankless by CCL
2026